Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature

Melanoma and Skin CancerVitiligo

Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma

JAMA Dermatol

Nakamura Y, Teramoto Y, Asami Y, Matsuya T, Adachi JI, Nishikawa R, Yamamoto A

doi: 10.1001/

Melanoma and Skin Cancer

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

BMC Cancer.

Ozaki Y, Shindoh J, Miura Y, Nakajima H, Oki R, Uchiyama M, Masuda J, Kinowaki K, Kondoh C, Tanabe Y, Tanaka T, Haruta S, Ueno M, Kitano S, Fujii T, Udagawa H, Takano T

doi: 10.1186/s12885-017-3785-4.

Melanoma and Skin Cancer

Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature

J Immunother.

Anastasopoulou A, Papaxoinis G, Diamantopoulos P, Christofidou E, Benopoulou O, Stratigos A, Gogas H

Melanoma and Skin CancerImmunotherapy

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Br J Dermatol.

Weber J, Glutsch V, Geissinger E, Haug L, Lock JF, Schneider F, Kneitz H, Goebeler M, Schilling B, Gesierich A

doi: 10.1111/bjd.18739.

Melanoma and Skin Cancer

Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy

Melanoma Res.

Plaquevent M, Greliak A, Pinard C, Duval-Modeste AB, Joly P

doi: 10.1097/CMR.

Melanoma and Skin Cancer

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Melanoma Res.

Dudda M, Mann C, Heinz J, Schmidgen I, Weid F, Kühn M, Saloga J, Grabbe S, Loquai C

doi: 10.1097/CMR.0000000000000703.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature

Melanoma Res.

Zafar FS, Richey P, Okereke U, Milhem M, Abid R, Powers JG, Swick B

doi: 10.1097/CMR.0000000000000713.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma

Melanoma Res.

Hanna DL, Law SJ, Merrick SA, Heptinstall L, Bass P, Dupont P, Sheri A

doi: 10.1097/CMR.0000000000000651.

Melanoma and Skin Cancer

Malignant melanoma metastasis in the gallbladder. A case report of an unusual metastatic site

Int J Surg Case Rep.

Hess GF, Glatz K, Rothschild SI, Kollmar O, Soysal SD, Boll DT, Droeser RA, Mechera R

doi: 10.1016/j.ijscr.2020.09.116.Visit the full text of the original publication at www.sciencedirect.com

Related content

Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease

Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature

The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma

Malignant melanoma metastasis in the gallbladder. A case report of an unusual metastatic site